Clinical characteristics and risk factors of HBV reactivation in cancer patients receiving immune checkpoints inhibitors

LEI Dingjia, LUO Huating, ZENG Yueying, LUO Haiying, WANG Rui, TANG Yao, QIN Bo

PDF(1051 KB)
PDF(1051 KB)
Chinese Journal of Infection and Chemotherapy ›› 2023, Vol. 23 ›› Issue (3) : 306-312. DOI: 10.16718/j.1009-7708.2023.03.005
Original Article

Clinical characteristics and risk factors of HBV reactivation in cancer patients receiving immune checkpoints inhibitors

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 23(3): 306-312 https://doi.org/10.16718/j.1009-7708.2023.03.005

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1051 KB)

Accesses

Citation

Detail
Sections
Recommended
沪ICP备11042064-1
Copyright © Chinese Journal of Infection and Chemotherapy, All Rights Reserved.
Address：12 Wulumuqi Zhong Road Shanghai, China　
Post Code：200040
Tel: 021-52888148　
　E-mail: cjic@fudan.edu.cn 或 hscjic@fudan.edu.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉